Amrad, Glaxo Wellcome sales and marketing update

Glaxo Wellcome will purchase on a non-exclusive basis AML's Amrad ICT point-of-care rapid diagnostic, which is marketed for hepatitis B, and distribute it in Asia with Glaxo's hepatitis B drug Zeffix...